Literature DB >> 17994373

Hb Kenya among Luo adults and young children in malaria holoendemic Western Kenya: screened by high performance liquid chromatography and confirmed by polymerase chain reaction.

Carolyne M Kifude1, Mark E Polhemus, D Gray Heppner, Mark R Withers, Bernhards R Ogutu, John N Waitumbi.   

Abstract

Hb Kenya, a fusion hemoglobin (Hb) resulting from a crossover between the (A)gamma- and beta-globin genes, is accompanied by an increased level of fetal Hb (Hb F) in adult life. This study describes the use of cation exchange high performance liquid chromatography (HPLC) in the identification of Hb Kenya and of a polymerase chain reaction (PCR) method for confirmatory diagnosis. Data came from 584 children and 406 adults who were screened for eligibility for malaria vaccine trials at Kombewa, Western Kenya. Sixteen subjects (13 children and three adults) had elevated Hb F (5.0-28.4%; normal <5.0%). Of these, 11 had an apparent markedly elevated Hb A(2) (9.2-22.9%) and were confirmed by gap-PCR as having the 22.7 kb deletion characteristic of Hb Kenya. Of the five cases with elevated Hb F but normal A(2), none had Hb Kenya. We propose that in this population, the finding by cation exchange HPLC of an elevated Hb F (>9.0%) and of an apparently increased Hb A(2) (>9.2%), may suggest the presence of Hb Kenya. However, given the inability of differentiating Hb Kenya from a truly elevated Hb A(2) by routine cation exchange HPLC, it is imperative to confirm the Hb Kenya mutation by gap-PCR.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17994373     DOI: 10.1080/03630260701587638

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  3 in total

1.  Hemoglobin variants identified in the Uganda Sickle Surveillance Study.

Authors:  Beverly A Schaefer; Charles Kiyaga; Thad A Howard; Grace Ndeezi; Arielle G Hernandez; Isaac Ssewanyana; Mary C Paniagua; Christopher M Ndugwa; Jane R Aceng; Russell E Ware
Journal:  Blood Adv       Date:  2016-11-22

2.  Evaluation of recurrent parasitemia after artemether-lumefantrine treatment for uncomplicated malaria in children in western Kenya.

Authors:  Joseph V Woodring; Bernhards Ogutu; David Schnabel; John N Waitumbi; Cara H Olsen; Douglas S Walsh; D Gray Heppner; Mark E Polhemus
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

3.  Differential Gene Expression in Host Ubiquitination Processes in Childhood Malarial Anemia.

Authors:  Samuel B Anyona; Evans Raballah; Qiuying Cheng; Ivy Hurwitz; Caroline Ndege; Elly Munde; Walter Otieno; Philip D Seidenberg; Kristan A Schneider; Christophe G Lambert; Benjamin H McMahon; Collins Ouma; Douglas J Perkins
Journal:  Front Genet       Date:  2021-11-22       Impact factor: 4.772

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.